Valamont Advisors, LLC
Contact us
  • Valamont
    • Valley to Peak
    • Strategy by Design
    • Contact Us
  • Services
    • Technology Strategy
    • Product Strategy
    • Franchise Strategy
  • Clients
    • Corporate Development
    • Research & Development
    • Commercial Development
  • Approach
    • Science Driven Strategy Design
  • Expertise
    • Technology Expertise
    • Sector Convergence
  • Insights
    • Technology Disruption
  • Team
    • Leadership
    • Advisors
    • Join Us
Our leadership team has proven experience delivering actionable value-creating strategies based on rigorous analysis and deep understanding of science and markets

Seasoned Advisors

Picture

  • Alumni of healthcare, pharma and life sciences practices of leading strategy consulting firms including McKinsey, LEK Consulting, Accenture, Scientia, Trinity Partners, Boston BioMedical
  • Worked with over 125 companies, including each of the top 10 pharma companies, every major biotech company, diagnostic company and reference lab, plus ~100 therapeutic, diagnostic, medical device and digital health innovators

Broad Experience

Picture
  • Advisory experience across all life sciences industry sectors, disease areas and geographies, and across the full product lifecycle from idea to product development through launch and brand and life cycle management
  • Covered all corporate development stages, from inception to IPO, spin-outs and acquisitions, with substantial experience forging partnerships to access and advance products and technologies
  • Deep industry experience leading Portfolio Strategy, Clinical, Market, Business and Corporate Development for pharma, biotech, genomics and digital health companies, from new ventures to global market leaders

Proven Value

Picture
  • Completed more than 100 transaction-related assignments with over 20 completed transactions exceeding $12B total deal value that have generated >$50B incremental shareholder value
  • Designed strategies for venture companies that collectively raised >$600M in IPOs valued at >$2.5B in total
  • Designed product development, launch, patient support or life-cycle strategies for brands with >$10B revenue

© Valamont Advisors, LLC  |  info@Valamont.com